New hope for breast cancer patients who stopped responding to standard drugs

NCT ID NCT07100106

Recruiting now Disease control Sponsor: Genentech, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug called GDC-4198 for people with advanced breast cancer that has stopped responding to standard treatments. Researchers will compare GDC-4198 alone and combined with another drug against the current standard treatment to see which works better and is safer. The trial is for people whose cancer has grown despite previous treatment with CDK4/6 inhibitor drugs.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Barbara Ann Karmanos Cancer Institute
RECRUITING

Detroit, Maine, 48201-2013, United States
Cancer Research SA
RECRUITING

Adelaide, South Australia, 5000, Australia
City of Hope
RECRUITING

Duarte, California, 91010, United States
City of Hope - Orange County Lennar Foundation Cancer Center
RECRUITING

Irvine, California, 92618, United States
City of Hope® Cancer Center Chicago
RECRUITING

Zion, Illinois, 60099, United States
Hospital Beata Maria Ana
RECRUITING

Madrid, 28007, Spain
Hospital Universitario 12 de Octubre
RECRUITING

Madrid, 28041, Spain
Institut Jean Godinot
RECRUITING

Reims, Champagne-Ardenne, 51100, France
Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612, United States
New York Cancer & Blood Specialists
RECRUITING

East Patchogue, New York, 11772, United States
Princess Margaret Hospital
RECRUITING

Toronto, Ontario, M5G 2M9, Canada
Rutgers Cancer Institute of New Jersey
RECRUITING

New Brunswick, New Jersey, 08901-1914, United States
St Vincent's Hospital Sydney
RECRUITING

Darlinghurst, New South Wales, 2010, Australia
UPMC - Hillman Cancer Center
RECRUITING

Pittsburgh, Pennsylvania, 15213-3108, United States
Washington University Siteman Cancer Center
RECRUITING

St Louis, Missouri, 63110-1010, United States
Winship Cancer Institute of Emory University
RECRUITING

Atlanta, Georgia, 30322-1013, United States

Conditions

Explore the condition pages connected to this study.

BREAST CANCER